You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Claims for Patent: 7,125,836


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,125,836
Title:Method of cancer screening; method of cancer treatment; and method of diabetes treatment
Abstract: A method of cancer screening comprising the steps of administering the Blood CA 27,29 testing procedure; if the result is positive administering a mammogram; if the result is positive administering a needle biopsy; if the result is positive administering a PET scan; if the result is positive administering a blood tumor cell count. If all of the foregoing steps are positive, the cancer is treated by applying imiquimod transdermally to rotating sites, preferably by mixing ALDARA (TM) (imiquimod) 5% cream with an equal amount of H base cream (TM); administering a vaccine that induces production of tumor necrosis factor, preferably the BCG vaccine; and orally administering Valtrex (TM) (valacyclovir) twice daily. The foregoing treatment method is also effective in treating Type I diabetes, MS, and other epidermal cancers.
Inventor(s): Woodward; John R. (Dallas, TX)
Assignee: Les Medecins L.P. (Dallas, TX)
Application Number:11/133,838
Patent Claims:1. A method of treating duct cell breast cancer in a patient comprising the steps of: providing a quantity of ALDARA.TM. (imiquimod) 5% cream; providing a quantity of H base cream.TM.; mixing 1/4 cc. Of the ALDARA.TM. (imiquimod) 5% cream with 1/4 cc. Of the H base cream.TM. and transdermally administering the resulting mixture, in conjunction with administering a BCG vaccine; and orally administering VALTREX.TM. (valacyclovir) tablets, to the patient.

2. The method of treating duct cell breast cancer according to claim 1 wherein the ALDARA (TM) (imiquimod) 5% cream/H base cream mixture is applied daily and the progress of the procedure is monitored using the Blood CA 27,29 testing procedure.

3. The method of treating duct cell breast cancer according to claim 1 wherein the BCG vaccine is administered every three weeks and 500 mg VALTREX (TM) (valacyclovir) tablets are orally administered twice daily.

4. The method of treating duct cell breast cancer according to claim 3 wherein the progress of the procedure is monitored using the Blood CA 27,29 testing procedure.

5. The method of treating duct cell breast cancer according to claim 2 wherein the Blood CA 27,29 testing procedure is administered prior to said treating, and treating is carried out if said testing procedure reveals the presence of duct cell breast cancer.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.